The global antipsychotic drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antipsychotic drugs are medications used to treat psychological disorders such as schizophrenia and bipolar disorder. Psychosis is a critical symptom that occurs due to mental illness, including loss with reality affecting how one processes information. Though, on contrary to the general perception, the possibility of men and women being affected by bipolar disorder is similar. Thus, the surge in the cases of the disease among females as well as males coupled with the rising need to manage the disease effectively is projected to lead to the demand for these drugs, thereby augmenting the growth of the global antipsychotic drugs market.

With the shifting perspective of the global population toward mental health, there is an increased demand for diagnosis and treatment of various mental disorders. Bipolar disorder, being one such prevalent issue, which is anticipated to spur its drugs market. As per the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, the prevalence of bipolar disorder across the world varies from 0.3 to 1.2% by country. In 2017 around 46 million people in the world had bipolar disorder, with 52% and 48% being female and male, respectively. The typical age of onset is the late teens or the early 20s, and a history of depression is common in people diagnosed with bipolar disorder. However, the high cost associated with the treatment of these mental issues is expected to hamper the market growth.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Application 

o By Drug Classification

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Pfizer Inc., Eli Lilly & Co., and AstraZeneca plc, among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Antipsychotic Drugs Market Report by Segment

By Application 

    • Dementia

    • Bipolar Disorder

    • Schizophrenia

    • Dementia

    • Others

By Drug Classification

    • First Generation (Typical)

    • Second Generation (Atypical)

Global Antipsychotic Drugs Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa